How Much Upside is Left in Acadia (ACAD)? Wall Street Analysts Think 38.62%Zacks Investment Research • 10/27/23
Acadia Pharmaceuticals to Announce Third Quarter Financial Results on November 2, 2023Business Wire • 10/19/23
Acadia (ACAD) Surges 8.3%: Is This an Indication of Further Gains?Zacks Investment Research • 09/28/23
Acadia Pharmaceuticals Appoints Albert Kildani as Senior Vice President, Investor Relations and Corporate CommunicationsBusiness Wire • 09/19/23
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Lawsuit Against Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) and Encourages Long-Term ACAD Investors to Contact the FirmPRNewsWire • 08/16/23
Acadia Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operating OverviewBusiness Wire • 08/02/23
Is ACADIA Pharmaceuticals (ACAD) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 07/21/23
Acadia Pharmaceuticals to Announce Second Quarter Financial Results on August 2, 2023Business Wire • 07/19/23
Acadia Pharmaceuticals Rights Deal and Bullish Outlook Sends Shares Surging 16%. Here's What to Expect.24/7 Wall Street • 07/18/23
Acadia's Newest Drug Just Obliterated Sales Expectations; Shares Hit Two-Year HighInvestors Business Daily • 07/14/23